Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
308.8 BRL | +4.18% | 0.00% | +17.40% |
18/06 | T. Rowe Price Unveils New, Patent-Pending Framework | CI |
12/06 | Goldman Sachs Raises T. Rowe Price's PT to $113 From $110 | MT |
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- For several months, analysts have been revising their EPS estimates roughly upwards.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Analyst opinion has improved significantly over the past four months.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- The company's enterprise value to sales, at 3.31 times its current sales, is high.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
Ratings chart - Surperformance
Sector: Investment Management & Fund Operators
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+17.40% | 2.62TCr | - | ||
-3.00% | 12TCr | A- | ||
+0.73% | 9.5TCr | C+ | ||
+26.92% | 6.74TCr | C | ||
+5.40% | 6.41TCr | - | B+ | |
+12.72% | 4.4TCr | C+ | ||
+14.23% | 4.35TCr | A- | ||
+27.59% | 3.8TCr | A- | ||
-5.94% | 2.19TCr | A- | ||
+1.23% | 1.88TCr | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- TROW Stock
- T1RO34 Stock
- Ratings T. Rowe Price Group, Inc.